Full Answer
Stenotrophomonas maltophilia has had multiple different names in the past. It was first found in a pleural effusion in 1943 and given the name Bacterium bookeri. It was then renamed to Pseudomonas maltophilia in 1961.
Chloramphenicol and rifampin may be the only options against Stenotrophomonas maltophilia. A tale of a colonized bladder device in a patient with myelofibrosis.
Stenotrophomonas maltophilia contamination of nebulizers used to deliver aerosolized therapy to inpatients with cystic fibrosis. J. Hosp. Infect.55:180–183 [PubMed] [Google Scholar] 81. Denton M, Todd NJ, Kerr KG, Hawkey PM, Littlewood JM. 1998.
Class 1 integrons increase trimethoprim-sulfamethoxazole MICs against epidemiologically unrelated Stenotrophomonas maltophilia isolates. Antimicrob. Agents Chemother.48:666–669 [PMC free article][PubMed] [Google Scholar] 28. Bathe S, Lebuhn M, Ellwart JW, Wuertz S, Hausner M. 2004.
B96. 89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM B96. 89 became effective on October 1, 2021.
R78. 81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
ICD-10 code: A49. 9 Bacterial infection, unspecified.
ICD-10 code B96. 89 for Other specified bacterial agents as the cause of diseases classified elsewhere is a medical classification as listed by WHO under the range - Certain infectious and parasitic diseases .
ICD-10 | Fever, unspecified (R50. 9)
BacteremiaICD-10 code R78. 81 for Bacteremia is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
A49. 9 - Bacterial infection, unspecified. ICD-10-CM.
A49. 9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Our physicians have used IDC-10 code F07. 81 as the primary diagnosis for patients presenting with post concussion syndrome.
6 for Staphylococcus aureus as the cause of diseases classified elsewhere is a medical classification as listed by WHO under the range - Certain infectious and parasitic diseases .
Bacteremia is the presence of bacteria in the blood, hence a microbiological finding. Sepsis is a clinical diagnosis needing further specification regarding focus of infection and etiologic pathogen, whereupon clinicians, epidemiologists and microbiologists apply different definitions and terminology.
ICD-10-CM Code for Sepsis due to Serratia A41. 53.
Stenotrophomonas maltophilia has had multiple different names in the past. It was first found in a pleural effusion in 1943 and given the name Bacterium bookeri. It was then renamed to Pseudomonas maltophilia in 1961. It was moved to the genus Xanthomonas in 1983, and most recently to Stenotrophomonas in 1993.
S. maltophilia frequently colonizes humid surfaces such as the tubes used in mechanical ventilation and indwelling urinary catheters as well as medical devices such as suction catheters and endoscopes. Infection is usually facilitated by the presence of prosthetic material (plastic or metal), and the most effective treatment is ...
The growth of S. maltophilia in microbiological cultures of respiratory or urinary specimens is difficult to interpret due to its low pathogenicity, and not a proof of infection.
Deliberate induction of inflammatory responses is the main pathogenic mechanisms of S. maltophilia infection. S. maltophilia secretes outer membrane vesicles (OMVs), that cause an inflammatory response. OMVs from S. maltophilia ATCC 13637 were found to be cytotoxic to human lung epithelial cells.
S. maltophilia is naturally resistant to many broad-spectrum antibiotics (including all carbapenems) due to the production of two inducible chromosomal metallo-β-lactamases (designated L1 and L2). This makes treatment of infected patients very difficult.
In immunocompetent individuals, S. maltophilia is a relatively unusual cause of pneumonia, urinary tract infection, or bloodstream infection; in immunocompromised patients, however, S. maltophilia is a growing source of latent pulmonary infections. S. maltophilia colonization rates in individuals with cystic fibrosis have been increasing.
In immunocompromised patients, S. maltophilia can lead to nosocomial infections. It is also an emerging nosocomial pathogen associated with opportunistic infections in patients with cystic fibrosis, cancer, and HIV. Adherence of this organism to abiotic surfaces such as medical implants and catheters represents a major risk for hospitalized ...